By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance
pathways. Our mission is to develop drugs that succeed and complement PARP inhibitors and facilitate the cure of therapy resistant cancers.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Essener Bogen, Hamburg,hh 22419,germany
- Phone
- +49 40 56081 180
- in****@****ttx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- breakpointtx.com
- Keywords
- Synbionik.
- HQ
- Hamburg, HH
Breakpoint Therapeutics Questions
Breakpoint Therapeutics's helpline number is +49 40 56081 180
Breakpoint Therapeutics's website is breakpointtx.com
Breakpoint Therapeutics's LinkedIn profile is https://de.linkedin.com/company/breakpoint-therapeutics
Breakpoint Therapeutics has
3 employees.
View email and phone details for 3
employees at Breakpoint Therapeutics.
Breakpoint Therapeutics's industry is
Biotechnology Research
Breakpoint Therapeutics's top competitors are
Pentixapharm Ag,
Pharmaventures,
Topas Therapeutics Gmbh,
Nicinbio Strategy,
Eisbach Bio Gmbh,
Facellitate,
Synbionik,
Scitaris,
Asc Oncology Gmbh,
Tacalyx Gmbh.
Breakpoint Therapeutics's support email address is info@breakpointtx.com
Breakpoint Therapeutics's categories are Biotechnology Research
Breakpoint Therapeutics's founding year is 2019
